Leadership, Trends & Investments

Featured September 10, 2021

Pharma Investment Round-up – 10/09/2021

This week – Sanofi seals the deal to expand its transplant medicine portfiolio; Hybrigienics approachs Bone Therapeutics again for a merger.

Leadership, Trends & Investments September 3, 2021

Pharma Investment Roundup – 3/9/2021

This week – Novartis and NHS England confirm deal to improve access to cholesterol drug Inclisiran; AstraZeneca Team Up With Thermo Fisher.

Featured August 27, 2021

Pharma Investment Roundup – 27/08/2021

In pharma investments, Pfizer Proposes to Buy Trillium for $2.3 billion; Lilly Collaborates with Lycia to Focus on Protein Degradation.

Featured August 20, 2021

Pharma Investment Roundup – 20/8/2021

In pharma investments, Prophase Labs acquires Nebula Genomics Solutions; Bayer agrees to acquire CDMO Irisys for $50 billion.

Featured August 6, 2021

Pharma Investment Roundup – 6/8/2021

This week in pharmaceutical investments, Sanofi acquires Translation Bio to boost its mRNA capabilities; and Bayer agrees to acquire Vividion Therapeutics for almost $2 billion.

Featured July 30, 2021

Pharma Investment Roundup – 30/7/2021

In investments: Kiromic acquires InSilico Solutions to accelerate its cancer IO; Organon collaborates with ObvsEva, growing its R&D portfolio.

Leadership, Trends & Investments July 23, 2021

Pharma Investment Roundup – 23/7/21

In pharma investments, BioIVT acquries biobank Tissue Solutions; Pacific Bio merges with biotech Ominome in $800 million deal.

Leadership, Trends & Investments July 16, 2021

Pharma Investment Roundup – 16/7/21

This week in pharma investments, Novo Nordisk expands its rare disease pipeline, and Biogen secures £125m deal with China-based InnoCare.

Leadership, Trends & Investments July 9, 2021

Pharma Investment Roundup – 9/7/21

This week in pharma investments, AstraZeneca forges ahead in recent biotech boom by buying Alexion; and GSK’s CEO remains under fire.

Leadership, Trends & Investments June 4, 2021

AstraZeneca/Alexion Purchase Held Up by CMA Amid Concerns

While the FTC has approved the AZ/Alexion merger, several regulators, including the CMA, have held out over possible competition concerns.

Leadership, Trends & Investments May 17, 2021

Future Trends for Pharma and Life Sciences 2021

Given the considerable seismic shifts occurring in the pharmaceutical and life sciences sectors recently, it is no surprise that the major trends and investments of 2021 have seen a similar change in focus. Alzheimer’s Disease, genome editing and cellular therapy are three areas which will see increased investment from the pharma industry in the coming […]

Leadership, Trends & Investments April 16, 2021

Emerging therapeutic areas of clinical attention & investment opportunities

Greater investment and clinical focus is need in specific therapeutic areas to better understand diseases with limited therapeutic options.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings

Blueprint of Hope: The Evolution of 3D Printing in Renal Transplantation

Redefining Clinical Excellence in Spinal Care Through AI: The Rise of Machine Learning in Diagnosis and Prognosis

Data Deluge in Modern Healthcare: Navigating the Big Data Ocean